Literature DB >> 2892572

Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat.

T K McIntosh1, V A Head, A I Faden.   

Abstract

Delayed injury following trauma to the central nervous system (CNS) may be due to the release or activation of endogenous factors. Endogenous opioid peptides have been proposed as one such class of injury factors, based on pharmacological studies demonstrating a therapeutic effect of naloxone and other opiate receptor antagonists following CNS injury. However, changes in brain opioid concentrations following injury have not been evaluated. In the present study, we measured regional alterations in dynorphin (ir-Dyn), leucine-enkephalin (ir-Enk) and beta-endorphin immunoreactivity (ir-End) following low- (1.0-2.0 atmospheres (atm)) or high- (3.0-4.0 atm) level fluid-percussion brain injury in the cat. A significant decrease in ir-End was observed in the hypothalamus at 2 h following high- but not low-level injury. No changes were observed in tissue ir-Enk following either level of injury. Severe brain trauma but not low-level injury caused a significant increase in ir-Dyn in the striatum, frontal cortex, parietal cortex, pons and medulla. In the anterior pituitary, a significant increase in ir-End and a significant decrease in ir-Dyn was observed at 2 h following both levels of injury. Pathological damage to brain tissue after injury was most pronounced in those regions showing significant increases in ir-Dyn but not other opioids. In the medulla, the increase in ir-Dyn but not ir-End or ir-Enk was also significantly correlated with a fall in systemic mean arterial pressure (MAP) at 2 h following high- but not low-level injury.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2892572     DOI: 10.1016/0006-8993(87)90505-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

Review 1.  Pathobiology of dynorphins in trauma and disease.

Authors:  Kurt F Hauser; Jane V Aldrich; Kevin J Anderson; Georgy Bakalkin; MacDonald J Christie; Edward D Hall; Pamela E Knapp; Stephen W Scheff; Indrapal N Singh; Bryce Vissel; Amina S Woods; Tatiana Yakovleva; Toni S Shippenberg
Journal:  Front Biosci       Date:  2005-01-01

2.  Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity.

Authors:  Amina S Woods; Rafal Kaminski; Murat Oz; Yun Wang; Kurt Hauser; Robin Goody; Hay-Yan J Wang; Shelley N Jackson; Peter Zeitz; Karla P Zeitz; Dorota Zolkowska; Raf Schepers; Michael Nold; Jens Danielson; Astrid Gräslund; Vladana Vukojevic; Georgy Bakalkin; Allan Basbaum; Toni Shippenberg
Journal:  J Proteome Res       Date:  2006-04       Impact factor: 4.466

3.  Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.

Authors:  K F Hauser; J K Foldes; C S Turbek
Journal:  Exp Neurol       Date:  1999-12       Impact factor: 5.330

4.  Hyperamylasemia after cardiac surgery. Incidence, significance, and management.

Authors:  D W Rattner; Z Y Gu; G J Vlahakes; A L Warshaw
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

Review 5.  Endogenous Opioid Dynorphin Is a Potential Link between Traumatic Brain Injury, Chronic Pain, and Substance Use Disorder.

Authors:  Kaitlin M Best; Marissa M Mojena; Gordon A Barr; Heath D Schmidt; Akiva S Cohen
Journal:  J Neurotrauma       Date:  2022-01       Impact factor: 4.869

6.  Alteration of opioid peptide concentrations in the rat pituitary following survivable closed head injury.

Authors:  O O Grigoriants; S V Pravdenkova; B J Andersen; D M Desiderio
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

7.  Repeated blast model of mild traumatic brain injury alters oxycodone self-administration and drug seeking.

Authors:  Natalie N Nawarawong; Megan Slaker; Matt Muelbl; Alok S Shah; Rachel Chiariello; Lindsay D Nelson; Matthew D Budde; Brian D Stemper; Christopher M Olsen
Journal:  Eur J Neurosci       Date:  2018-12-14       Impact factor: 3.386

8.  Chronic post-traumatic headache: clinical findings and possible mechanisms.

Authors:  Ruth Defrin
Journal:  J Man Manip Ther       Date:  2014-02

9.  Mass Spectrometric Imaging of Ceramide Biomarkers Tracks Therapeutic Response in Traumatic Brain Injury.

Authors:  Damon C Barbacci; Aurelie Roux; Ludovic Muller; Shelley N Jackson; Jeremy Post; Kathrine Baldwin; Barry Hoffer; Carey D Balaban; J Albert Schultz; Shawn Gouty; Brian M Cox; Amina S Woods
Journal:  ACS Chem Neurosci       Date:  2017-08-14       Impact factor: 4.418

10.  Turning the 'Tides on Neuropsychiatric Diseases: The Role of Peptides in the Prefrontal Cortex.

Authors:  Dakota F Brockway; Nicole A Crowley
Journal:  Front Behav Neurosci       Date:  2020-10-20       Impact factor: 3.558

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.